Effectiveness and safety of adjunctive traditional Chinese medicine therapy for primary liver cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and safety of adjunctive traditional Chinese medicine therapy for primary liver cancer patients

Published:2020-07-31 Issue:31 Volume:99 Page:e21281
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Li Tingting,Zhang Xiaona,Xu Shanshan,Cheng Hongjie,Zhang Hong

Funder

Beijing national key specialty of traditional Chinese medicine radiation engineering capital regional specialty

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference15 articles.

1. Estimation and analysis of the incidence of liver cancer in China;Chen;China Cancer,2005

2. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

3. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma;Zhou;J Clin Oncol,2011

4. Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: a review;Chen;J Chin Integr Med,2008

5. Liver cancer: targeted future options;Pircher;World J Hepatol,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruangan Lidan decoction inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK4;Cancer Biology & Therapy;2023-09-29

2. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia;Journal of Integrative Medicine;2023-09

3. Exploration of the potential mechanism of the Fuzheng Xiegan decoction for treating hepatocellular carcinoma based on experimental and network pharmacological analyses;European Journal of Integrative Medicine;2023-06

4. EFFECT OF INDOCYANINE GREEN (ICG)-MEDIATED NEAR-INFRARED LIGHT GUIDED LIVER TUMOR RESECTION ON THE PROGNOSIS OF PATIENTS WITH PRIMARY LIVER CANCER;ACTA MEDICA MEDITERR;2022

5. miR-381 Reverses Multidrug Resistance by Negative Regulation of the CTNNB1/ABCB1 Pathway in HepG2/Dox Cells, and the Diagnostic and Prognostic Values of CTNNB1/ABCB1 Are Identified in Patients with LIHC;DNA and Cell Biology;2021-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3